Ginns E, French J, Fleischman A, Cohen S
Pediatr Res. 1980 Nov;14(11):1276-7. doi: 10.1203/00006450-198011000-00025.
GM1 ganglioside concentration was measured by radioassay technique in individual samples of lumbar cerebrospinal fluid from 20 neonatal and 17 older pediatric patients. The lumbar CSF GM1 ganglioside concentration of neonates (76.6 +/- 27.4 ng/ml) is greater than that of older infants and children (31.9 +/- 22.2 ng/ml). The lower range of GM1 ganglioside concentration of CSF from older pediatric patients is similar to the previously reported adult CSF values. The mean CSF GM1 ganglioside concentration in pediatric patients with active neurologic disease (53.1 +/- 30.0 ng/ml) is greater than that of children without central nervous system pathology. The temporal evolution and magnitude above baseline values of lumbar CSF GM1 ganglioside concentration in three neonates was correlated with the clinical status of these patients.
采用放射分析技术测定了20例新生儿和17例大龄儿科患者腰椎脑脊液的个体样本中GM1神经节苷脂浓度。新生儿腰椎脑脊液GM1神经节苷脂浓度(76.6±27.4 ng/ml)高于大龄婴幼儿和儿童(31.9±22.2 ng/ml)。大龄儿科患者脑脊液GM1神经节苷脂浓度的下限与先前报道的成人脑脊液值相似。患有活动性神经疾病的儿科患者脑脊液GM1神经节苷脂平均浓度(53.1±30.0 ng/ml)高于无中枢神经系统病变的儿童。3例新生儿腰椎脑脊液GM1神经节苷脂浓度高于基线值的时间演变及幅度与这些患者的临床状况相关。